Results 261 to 270 of about 196,988 (294)

Hypertension and left ventricular hypertrophy

Journal of Hypertension
In the initial stage, left ventricular hypertrophy (LVH) is adaptive, but in time, it transforms to maladaptive LVH which is specific for the development of various phenotypes that cause heart failure, initially with preserved, but later with reduced left ventricular ejection fraction.
Dragan B, Đorđević, Goran P, Koračević, Aleksandar D, Đorđević, Dragan B, Lović   +3 more
openaire   +2 more sources

Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis

Lancet, The, 2021
Marc S Sabatine, Patrick W Serruys, Duk-Woo Park   +2 more
exaly  

Posterior left pericardiotomy for the prevention of atrial fibrillation after cardiac surgery: an adaptive, single-centre, single-blind, randomised, controlled trial

Lancet, The, 2021
Mario F L Gaudino, Tommaso Sanna, Karla V Ballman   +2 more
exaly  

Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

Lancet, The, 2020
Niels R Holm, Andrejs Erglis, Keith G Oldroyd   +2 more
exaly  

Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management

Ca-A Cancer Journal for Clinicians, 2016
Giuseppe Curigliano, Daniela Maria Cardinale, Susan Dent   +2 more
exaly  

[Cardiac hypertrophy, ventricular hypertrophy (left ventricular hypertrophy, right ventricular hypertrophy, combined ventricular hypertrophy)].

Ryoikibetsu shokogun shirizu, 1997
F, Nakano, S, Arima, H, Tanaka
openaire   +1 more source

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

Lancet, The, 2009
Vivek Y Reddy
exaly  

Ventricular Hypertrophy, Left

2009
Wendy Balemans, Wim Van Hul, Marian Valko, Jan Moncol, Lee A. Denson, Maria Mela, Ulrich Thalheimer, Dimitrios Samonakis, Andrew K. Burroughs, Alexander K. C. Leung, Reginald S. Sauve, William Lane M. Robson, Stefan R. Bornstein, Marina Aunapuu, Andres Arend, Mike Recher, Karl S. Lang, Arthur Melms, Mike Recher, Karl S. Lang, Mike Recher, Karl S. Lang, Cord Sunderkötter, Anca Sindrilaru, Maria Teresa Divizia, Margherita Lerone, Roberto Ravazzolo, Vimla S. Aggarwal, Jelena S. Arnold, Anna Blonska*, Bernice E. Morrow, Ralf Kubitz, Takashi Yamaki, Alexander K. C. Leung, Kim A. Connelly, Richard E. Gilbert, Lucia K. Ma, Patrick T. S. Ma, Alexander K. C. Leung, Narain Moorjani, Peter H. Sugden, Christophe Depre, Joseph B. Selvanayagam, Annika Burow, Etienne Delacrétaz, Zhuang Chen, Weinian Shou, Eggert Stockfleth, Ingo Nindl, Thomas Brandt, Michael Strupp, Diethilde Theil, Brage Storstein Andresen, Amei Ludwig, Hartmut Hengel, Johannes G. Bode, Andreas Erhardt, Guido Oppido, Carlo Pace Napoleone, Gaetano Gargiulo, Hans K. Biesalski, Hans K. Biesalski, Hans-Jürgen Gdynia, Albert C. Ludolph, Roland Bitsch, Naidu K. Akhilender, Naidu K. Akhilender, Armin Zittermann, Armin Zittermann, Angelo Azzi, Yesim Negis, Angelo Azzi, Yesim Negis, Arie Markel, Nir Kfir, Arie Markel, Nir Kfir, Johannes Bayer, Stefan Beissert, Janice Y. Chou, Brian C. Mansfield, Arndt Hartmann, Wolfgang Dietmaier, Hugo Ten Cate   +83 more
openaire   +1 more source

Left ventricular hypertrophy

The American Journal of Cardiology, 1965
Kassem Hatam, Ulf Rudhe, Göran Wallgren
openaire   +1 more source

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

Lancet, The, 2003
Jan Östergren, Karl Swedberg, Christopher B Granger   +2 more
exaly